Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2008 Sep-Oct;56(5):439-40.
doi: 10.4103/0301-4738.42431.

Contact allergic dermatitis and periocular depigmentation after using olapatidine eye drops

Smitha T Suchi, Arvind Gupta, Renuka Srinivasan
Case Reports

Contact allergic dermatitis and periocular depigmentation after using olapatidine eye drops

Smitha T Suchi et al. Indian J Ophthalmol. 2008 Sep-Oct.
No abstract available

PubMed Disclaimer

References

    1. Lichtenstein SJ, Pasquine TA, Edwards MR, Wells DT, Gross RD, Robertson SM. Safety and tolerability of olopatadine 0.2% in children and adolescents. 2007;23:366–71. - PubMed
    1. Abelson MB. A review of olopatadine for the treatment of ocular allergy. Exp Opin Pharmacother. 2004;5:1979–94. - PubMed
    1. Abelson MB, Gomes PJ, Vogelson CT, Pasquine TA, Gross RD, Turner FD, et al. Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: A randomized, double-masked environmental study. Clin Ther. 2004;26:1237–48. - PubMed
    1. Katelaris CH, Ciprandi G, Missotten L, Turner FD, Bertin D, Berdeaux G, et al. A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis. Clin Ther. 2002;24:1561–75. - PubMed
    1. Spangler DL, Bensch G, Berdy GJ. Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% opthalmic solution in the conjunctival allergen challenge model. Clin Ther. 2001;23:1272–80. - PubMed

MeSH terms